Form4insider filings, from the source

SEC Form 4 · accession 0001055726-19-000013

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2019M5,333—A783,625D
Common StockF2Mar 9, 2019M10,000—A793,625D
Common StockF3Mar 10, 2019M11,667—A805,292D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 9, 2019M5,333D——Common Stock5,3330D
Restricted Stock UnitF2—Mar 9, 2019M10,000D——Common Stock10,0000D
Restricted Stock UnitF3—Mar 10, 2019M11,667D——Common Stock11,66711,666D
Common Stock OptionF4$3.34Mar 8, 2019A60,000AMar 8, 2019Mar 8, 2029Common Stock60,00060,000D
Restricted Stock UnitF5—Mar 8, 2019A35,000A——Common Stock35,00035,000D

Explanation of responses